The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...

The healthcare sector has struggled to deliver worthwhile returns for investors since 2021, weighed down by several headwinds ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

The simplest way to invest in stocks is to buy exchange traded funds. But you can do a lot better than that by ...

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2024 financial results on Monday, February 10, 2025 after the financial markets close. The company will ...

The S&P 500 declined by 0.5% on Friday, Jan. 31, as investors digested the White House’s proposed tariffs on Canada, China, and Mexico.

Microsoft, Amazon and Google have all embraced new open-source DeepSeek AI technology from a Chinese company, despite its ...

Amazon AMZN has rallied 48.9% in the past year on the back of exceptional business execution and groundbreaking AI ...